Identifying and mitigating risks in the viral vector supply chain

Interviewees: Claire Wartel & Ulises Villavicencio

Discover our podcast session containing seven tracks on Identifying and mitigating risks in the viral vector supply chain featuring Claire Wartel, PhD, Director of Quality and Compliance at Polyplus-transfection and Ulises Villavicencio, Quality Auditor at Audentes Therapeutics.

These two experts discussed:

  • Critical pain points for cell and gene therapy companies
  • The importance of the quality of raw materials
  • The GMP subject in a manufacturing process
  • Quality requirements needed from regulatory agencies
  • The complexity of the cell & gene supply chain
  • Polyplus’ assets in this challenging environment

 

Get the PDF version

 

Partners:

bioinsights-logo